July 31st, 2019
Almac Group is proud of its global reputation for excellence, delivering expertise right across the drug development lifecycle and offering a tailored solution to each client.
Our client relationships are long term and they are underpinned by one simple commitment:
We will be exceptional, always.
Latest from Almac
June 13th, 2019
Almac Group Launches Almac Adapt™ – a New Patient-centric Supply Solution
June 03rd, 2019
Almac Group Reports Further Growth During Period of Significant Global Expansion
October 16th, 2018
Almac Launches Brexit Resource Hub
Partnering to advance human healthExplore our locations
Brexit - A Seamless Solution
Almac recognises that you need bespoke solutions to suit your needs. Only we can combine the expertise from our world leading range of specialised drug development services to support you across the full biopharmaceutical product lifecycle, from the preclinical stages through to commercialisation.
Almac Diagnostic Services is our stratified medicine business unit, specialising in biomarker driven clinical trials. Our global laboratories, in the UK and US, offer tailored solutions from discovery to commercialisation: biomarker discovery, assay development & validation, CDx development & commercialisation. Your clinical trial diagnostic partner.
Almac Discovery is a research driven, oncology business unit within Almac dedicated to the discovery and development of novel, innovative approaches to the treatment of cancer. We focus on early stage development and partner programmes with the pharmaceutical industry at the discovery to preclinical stage.
Next Generation Dx Summit
20 August 2019 Washington, DCEvent info
CPhI Korea 2019
21 August 2019 Seoul, KoreaEvent info
9th International Meeting on Antimicrobial Peptides (IMAP) 2019
28 August 2019 Utrecht, NetherlandsEvent info
International Symposium on Synthesis and Catalysis 2019 (ISySyCat2019)
03 September 2019 Evora, PortugalEvent info